Table 3.

Procedural safety and short-term outcome of percutaneous LAA occlusion

Reference	Patients (n)	Successful implantation (%)	Pericardial effusion (%)	Device embolisation (%)	Bail-out surgery (%)	Stroke/ embolism (%)	Major bleeding (%)	Death
PLAATO
Sievert et al75	15	100	6.7	0	0	0	0	0
Hanna et al76	11	100	0	0	0	0	0	0
Ostermayer et al77	111	97	4.6	0	0.9	0	–	0.9
El-Chami et al78	11	100	0	0	0	0	–	0
De Meester (2008)79	10	90	0	11.1	0	0	–	0
Ussia et al80	20	90	5.6	0	0	0	0	0
Park et al81	73	100	1.4	1.4	1.4	1.4	–	1.4
Block et al82	64	98	1.6	–	1.6	–	–	1.6
Bayard et al83	180	90	3.3	0.6	1.1	–	–	1.1
Viles-Gonzalez et al64	22	100	4.5	0	0	0	–	0
Watchman
Sick et al84	66	88	3.0	3	1.5	0	1.5	0
Holmes et al55	463 (PAF)	88	4.8	0.6	1.9	0.2	–	0
Reddy et al60	460 (CAP)	95	2.2	0	0.2	0	0.7	0
Kim et al85	5	100	0	0	0	0	0	0
Swaans et al86	10	100	0	10.0	0	0	10.0	0
Bai et al87	58	100	1.7	0	0	0	0	0
Swaans et al88	30	100	0	3.3	0	0	0	0
Reddy et al56	150	95	1.3	1.3	–	0	–	0
ACP
Park et al89	137	96	3.6	1.5	–	2.2	0	0
Lam et al90	20	95	0	0	0	–	0	0
Montenegro et al91	5	100	0	0	0	0	0	0
Danna et al92	37	92	2.9	5.9	0	0	–	0
López-Mínguez et al72	35	97	0	0	0	0	0	0
Helsen et al93	15	100	0	0	0	6.7	0	0
Nietlispach et al94*	152	96	2.6	4.6	3.3	2.0	–	0
Freixa et al33	42	100	0	0	0	0	0	0
Urena et al95	52	98	1.9	1.9	0	0	3.8	0
Streb et al96	21	95	4.8	0	0	0	0	0
Meerkin et al97	100	100	1.0	0	0	0	0	0
Faustino et al98	21	96	0	0	0	0	0	0
Plicht et al57	34	100	2.9	0	0	0	5.9	0
Apostolos et al62	969	97	1.2	0.2	–	0.7	1.2	0.6

*Nietlispach et al⁹⁴: non-dedicated LAA occlusion devices were used in 32 patients, dedicated (ACP) in 120 patients.

ACP, Amplatzer cardiac plugs; LAA, left atrial appendage.